Sterling Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Sterling Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$6.78K	Buy	1,572 +1,404	+836%	+$6.65K	﹤0.01%	2721
2026 Q2	$764	Sell	168 -572	-77%	-$2.27K	﹤0.01%	3180
2026 Q1	$2.96K	Sell	740 -631	-46%	-$3.09K	﹤0.01%	2897
2025 Q4	$9.6K	Buy	1,371 +373	+37%	+$2.09K	﹤0.01%	2623
2025 Q3	$4.64K	Buy	998 +659	+194%	+$3.09K	﹤0.01%	2784
2025 Q2	$1.85K	Buy	+339	New	+$1.82K	﹤0.01%	2936

Other funds holding TLSI

CWA Asset Management Group Naples, Florida $3.39B AUM 25.16% 1-Year Est. Return

Connecticut Wealth Management Farmington, Connecticut $2.73B AUM 14.39% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Root Financial Partners Encinitas, California $2.98B AUM 13.9% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Sterling Capital Management's TLSI Position: Q3 2026 in Review

Sterling Capital Management increased its TriSalus Life Sciences (TLSI) stake by 836% in Q3 2026, buying an estimated $6.65K and bringing the position to 1,572 shares worth $6.78K. The position accounts for ﹤0.01% of the portfolio, ranked #2721.

Sterling Capital Management first reported a position in TLSI in Q2 2025 and has held it in 6 quarters since. The position peaked at $9.6K in Q4 2025. 12 funds tracked by Wall St. Rank hold TLSI as of Q3 2026.

Sterling Capital Management held 1,572 shares of TriSalus Life Sciences worth $6.78K as of Q3 2026.
Sterling Capital Management bought 1,404 TriSalus Life Sciences shares in Q3 2026, an estimated $6.65K.
TriSalus Life Sciences made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #2721 holding.
Sterling Capital Management first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 6 quarters since.
Sterling Capital Management's TriSalus Life Sciences position peaked at $9.6K in Q4 2025.
12 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.